Drug Companies Spend Record On Lobbying

Law360, New York (April 3, 2007, 12:00 AM EDT) -- Health companies spent $182 million lobbying Capitol Hill between January 2005 and June 2006, setting a record as they weighed in on issues from drug prices to drug safety, a public interest group has found.

Drug makers shelled out the bulk of that sum, spending $155 million and hiring 1,100 lobbyists to fight for such issues as keeping cheaper Canadian pharmaceuticals out of the country and protecting lucrative drug patents, a study by the Center for Public Integrity said.

Pharmaceutical companies “have been facing an increasingly...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.